Bo Lennernas

Overview

Explore the profile of Bo Lennernas including associated specialties, affiliations and a list of published articles.

Snapshot

Articles 40

Citations 500

Followers 0

Related Specialties

Oncology

Allergy & Immunology

Pathology

Top 10 Co-Authors

Sten Nilsson

Per Albertsson

Yvonne Brandberg

Klas Norrby

Anders Ullen

Hans Lennernas

Khairul Majumder

Ulrika Harmenberg

Hemming Johansson

Enrique Castellanos

Published In

Acta Oncol

APMIS

Int J Oncol

Scand J Urol Nephrol

Oncol Rep

Affiliations

Soon will be listed here.

Recent Articles

High rate of local control and cure at 10 years after treatment of prostate cancer with external beam radiotherapy and high-dose-rate brachytherapy: a single centre experience

Hjalm-Eriksson M, Nilsson S, Brandberg Y, Johansson H, Lennernas B, Lundell G, et al.

Acta Oncol . 2021 Sep; 60(10):1301-1307. PMID: 34498986

Background And Purpose: To analyse the cumulative incidence of any failure (AF), prostate cancer-specific failure (PCSF), any death (AD), prostate cancer-specific death (PCSD), and local control in 2387 men with...

High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer: long-term experience of Swedish single-center

Johansson B, Staby Olsen J, Karlsson L, Lundin E, Lennernas B

J Contemp Brachytherapy . 2021 Jun; 13(3):245-253. PMID: 34122563

Purpose: Until now, most long-term results for brachytherapy only has been published for low-dose-rate (LDR) seeds. Due to radiobiology reasons, high-dose-rate (HDR) mono-brachytherapy is of growing interest. The aim of...

Effect on prostate volume following neoadjuvant treatment with an androgen receptor inhibitor monotherapy versus castration plus an androgen receptor inhibitor in prostate cancer patients intended for curative radiation therapy: A randomised study

Majumder K, Brandberg Y, Johansson H, Castellanos E, Ullen A, Lennernas B, et al.

Mol Clin Oncol . 2018 Feb; 8(1):141-146. PMID: 29387407

To avoid pubic arch interference, prostate cancer patients are treated with neoadjuvant androgen deprivation therapy (ADT) to achieve prostate volume (PV) reduction prior to radiation treatment. The aim of the...

An Intraprostatic Modified Release Formulation of Antiandrogen 2-Hydroxyflutamide for Localized Prostate Cancer

Tammela T, Haggman M, Ladjevardi S, Taari K, Isotalo T, Lennernas H, et al.

J Urol . 2017 Jul; 198(6):1333-1339. PMID: 28736321

Purpose: We investigated the tolerability, safety and antitumor effects of a novel intraprostatic depot formulation of antiandrogen 2-hydroxyflutamide (in NanoZolid®) in men with localized prostate cancer. Materials And Methods: Two...

Neurovascular Bundle Infiltration Can Explain Local Relapses Using Conformal Radiotherapy of Prostate Cancer

Johansson A, Lennernas B, Isacsson U

Anticancer Res . 2017 Apr; 37(4):1825-1830. PMID: 28373447

Aim: To quantify the impact of decreased margins for two treatment techniques, three-dimensional conformal radiotherapy (3D-CRT) and volumetric-modulated arc therapy (VMAT), on local control in curative treatment of prostate cancer....

Higher sexual interest with androgen receptor inhibitor monotherapy than with castration plus an androgen receptor inhibitor in prostate cancer patients treated with curative radiotherapy, but otherwise small health-related quality of life...

Majumder K, Nilsson S, Johansson H, Ullen A, Lennernas B, Bergenmar M, et al.

Eur J Cancer . 2016 Jul; 65:43-51. PMID: 27459586

Purpose: To prospectively study differences in health-related quality of life (HRQoL) in patients with localised/locally advanced prostate cancer (PC) treated with curative intended radiation therapy and randomised to androgen receptor...

Radical prostatectomy versus high-dose irradiation in localized/locally advanced prostate cancer: A Swedish multicenter randomized trial with patient-reported outcomes

Lennernas B, Majumder K, Damber J, Albertsson P, Holmberg E, Brandberg Y, et al.

Acta Oncol . 2014 Nov; 54(6):875-81. PMID: 25362844

Background: Treatment of localized prostate cancer (PC) is controversial. This is the first randomized study comparing an open surgery procedure (radical prostatectomy) with a combination of high-dose rate brachytherapy (2×10...

Long-term health-related quality of life after curative treatment for prostate cancer: a regional cross-sectional comparison of two standard treatment modalities

Hjalm-Eriksson M, Lennernas B, Ullen A, Johansson H, Hugosson J, Nilsson S, et al.

Int J Oncol . 2014 Oct; 46(1):381-8. PMID: 25355465

Effects on long-term health-related quality of life (HRQoL) were evaluated in patients treated for localized prostate cancer by two standard modalities: radical retropubic prostatectomy (RP) and external beam radiotherapy combined...

Pharmacokinetics of an injectable modified-release 2-hydroxyflutamide formulation in the human prostate gland using a semiphysiologically based biopharmaceutical model

Sjogren E, Tammela T, Lennernas B, Taari K, Isotalo T, Malmsten L, et al.

Mol Pharm . 2014 Jul; 11(9):3097-111. PMID: 25055161

The local distribution of 2-hydroxyflutamide (2-HOF) in prostate tissue after a single intraprostatic injection of a novel parenteral modified-release (MR) formulation in patients with localized prostate cancer was estimated using...

10.

Early salvage radiation therapy combined with short-term hormonal therapy in recurrent prostate cancer after radical prostatectomy: single-institution 4-year data on outcome, toxicity, health-related quality of life and co-morbidities from 184...

Cortes-Gonzalez J, Castellanos E, Sandberg K, Eriksson M, Wiklund P, Carlsson S, et al.

Int J Oncol . 2012 Nov; 42(1):109-17. PMID: 23151842

The aim of this study was to investigate the role of 70 Gy salvage radiotherapy (SRT) combined with short-term neoadjuvant hormonal therapy (NHT) in the treatment of recurrent disease after...